Web Desk
The Indian Council of Medical Research (ICMR) has partnered with Bharat Biotech International Limited (BBIL) to fast track clinical trials of the indigenous COVID-19 vaccine. ICMR’s National Institute of Virology (NIV) in Pune has provided the virus strain to BBIL to develop the vaccine.
The clinical trials will be held in 12 institutes across the country. In a letter to these institutes, the ICMR stated that it aims to launch the vaccine for public health use by August 15, after completion of all clinical trials.
Meanwhile, India’s second COVID-19 vaccine produced pharma giant Zydus Cadila got approval from the Drug Controller General of India (DCGI) to conduct phase I and phase II human clinical trials.
By Joseph Maliakan The new Bill introduced by the Union government , Viksit Bharat -…
By Joseph Maliakan Betrand Russel, plilosopher and logician was arrested in 1961 at the ripe…
Joseph Maliakan The Supreme Court of India on Thursday 27 November 2025 suggested the Union…
Joseph Maliakan Seven months of January to July 2025 , witnessed an unprecedented 334 incidents…
Muscat : Set to take place in Muscat this October, the 2025 edition of the…
Dubai: ADNOC Gas has entered into a 10-year agreement to supply liquefied natural gas (LNG)…
This website uses cookies.